Article Name Hospital & Healthcare
BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the updated BD Alaris™ Infusion System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), which enables both remediation and a return to full commercial operations for the most comprehensive infusion system available in the United States.
24th July, 2023
Essentials of ensuring cybersecurity in the IoMT and telemedicine landscape
Jess Ng, Country Head of Singapore and Brunei at Fortinet, unravels best practices to mitigate cyber security risks in the healthcare, clinical and pharma ecosystem
24th July, 2023
Medlinker's MedGPT Performs 96% As Well As Top Human Doctors
In a Livestreamed Real-World Assessment, MedGPT's AI Doctors Rival Diagnostic Accuracy of China's Leading Doctors
24th July, 2023
UroMems Announces First-Ever Smart Artificial Urinary Sphincter Implant in a Female Patient
Initial clinical study results will inform pivotal clinical trial in U.S. and Europe
21st July, 2023
Lark Health and Desert Oasis Healthcare Announce Expanded Partnership
Lark Health, the leading AI-powered digital care coaching company for the prevention and management of chronic conditions, and Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, today announced their expanded partnership where DOHC will offer Lark's Prevention program and CDC-recognized Diabetes Prevention program to their patients.
21st July, 2023
Olympus Launches Gastrointestinal Disease Diagnosis Project in Kenya
Selected by the National Center for Global Health and Medicine under the Ministry of Health, Labour and Welfare, Japan as "Projects for Global Growth of Medical Technologies, in 2023"
21st July, 2023
Verantos' AI Advancement in Neurology Bolstered by Groundbreaking Migraine Real-World Evidence
Technology enables inference of subjective outcomes from routinely collected data
20th July, 2023
Vial Enrolls First Patient in "OcuCool" Precision Cooling Trial Sponsored by RecensMedical
Vial, a leading global contract research organization (CRO) providing next-generation clinical trial management services, announced the enrollment of the first patient in the pivotal clinical trial, "COOL-3s", evaluating the OcuCool system, developed by RecensMedical, Inc. ("RecensMedical"), a distinguished medical device company based in South Korea.
20th July, 2023
Astellas and Eko Health Partner to Integrate Eko CORE 500™ Stethoscope into Z1608 for Heart Failure Patients
Transforming Heart Failure Management: Astellas, Eko Health & Welldoc Collaborate
19th July, 2023
Hackensack Meridian JFK University Medical Center Performs First Robotic Surgery with Heated Chemotherapy for Malignant Thymoma
Surgeons in the Division of Thoracic Surgery at JFK University Medical Center first in the State of New Jersey to perform this surgery
19th July, 2023
Mylab launches MyBox+ device with proprietary Dry Luminescence Immunoassay technology
Marks a departure from traditional liquid reagent-based testing methods
19th July, 2023
Hospital Pacifica Salud Teams Up with Global Healthcare Resources for Medical Travel in Panama
Pacifica Salud Hospital has joined the Global Provider Network (GPN), ushering in a new era of streamlined and easy access for American consumers and self-funded employers to access one of Latin America's top healthcare providers.
18th July, 2023
Devyser's NGS Products for Kidney Transplants Get IVDR Approvals
Devyser's novel test for detecting donor-derived cell-free DNA in blood samples from kidney-transplant patients and its product for screening and follow-up of stem cell transplanted patients fulfill IVDR requirements in Europe. These tests are the first post-transplant monitoring NGS products to be approved under the new, more comprehensive regulation that came into force in May 2022 and confirm Devyser's two NGS products meet the established safety, efficacy, and quality requirements.
18th July, 2023
Optina's REPHRASE Study Validates Innovative Alzheimer's Test
Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments.
18th July, 2023
Pluss Advanced Technologies enhances availability of neonatal cooling device 'MiraCradle'
UK-based The Rodnight Partnership ties up with India's Pluss
18th July, 2023
Aster DM Healthcare Successfully Rebrands Ramesh Hospitals to Aster Ramesh Hospitals
Affirms Strong Performance and Focus on India Amidst Ongoing Expansion
17th July, 2023
Yashoda Hospital, Kaushambi forays into genomic testing in collaboration with HaystackAnalytics
Brings Delhi’s first-ever comprehensive preventive health solution called Smart Gene Plan
17th July, 2023
Metropolis Healthcare launches advanced diagnostic lab in Kunnamkulam, Kerala
Extending high-quality testing services to patients with latest & innovative diagnostic technologies
17th July, 2023
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer